期刊文献+

利福昔明预防和治疗肝性脑病的研究进展 被引量:2

Rifaximin for prevention and treatment of hepatic encephalopathy
下载PDF
导出
摘要 肝性脑病(hepatic encephalopathy,HE)是肝脏功能衰竭或门体分流引起的严重中枢神经系统神经精神综合症,严重影响着人们的身心健康.其发病机制目前尚不明确,但是氨中毒学说占主要地位,那么围绕着降氨的治疗是治疗HE的重要方法之一.本文旨在讨论利福昔明预防和治疗HE疗效的进展. Hepatic encephalopathy(HE) is a serious neuropsychiatric syndrome of the central nervous system caused by liver failure or portosystemic shunt,seriously affecting patients' physical and mental well being.Although the pathogenesis of HE is still unclear at present,ammonia poisoning is believed to play a dominant role.Thus,reduction of ammonia is an important treatment for HE.This paper discusses the role of rifaximin in the prevention and treatment of HE.
作者 叶江锋 琚坚
出处 《世界华人消化杂志》 CAS 2015年第7期1090-1096,共7页 World Chinese Journal of Digestology
关键词 肝性脑病 利福昔明 预防 治疗 Hepatic encephalopathy Rifaximin Prevention Treatment
  • 相关文献

参考文献3

二级参考文献55

  • 1贾克丽,马应杰,冯素萍,方立峰,郭云霞.雅博司治疗肝硬化并发肝性脑病的临床对照研究[J].中原医刊,2006,33(3):32-33. 被引量:2
  • 2Bass NM,Mullen KD,Sanyal A,et al.Rifaximin treatment in hepatic encephalopathy[J].N Engl J Med.2010,362(12):1071-1081.
  • 3Schafer DF, Jones EA. Hepatic encephalopathy. In: Zakim D, Boyer TD, editors. Hepatology. A textbook of liver disease. Philadelphia: W. B. Saunders, 1990: 447-460.
  • 4Abou-Assi S, Vlahcevic ZR. Hepatic encephalopathy. Meta- bolic consequence of cirrhosis often is reversible. Postgrad Med 2001; 109: 52-54, 57-60, 63-65, passim.
  • 5de Melo RT, Charneski L, Hilas O. Rifaximin for the treat- ment of hepatic encephalopathy. Am J Health Syst Pharm2008; 65: 818-822.
  • 6Fitz G. Hepatic encephalopathy, hepatopulmonary syn- drome, coagulopathy and other complications of chronic liver disease. In: Feldman M, Friedman LS, Sleisenger MH, editors. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 7th ed. Philadelphia: Saunders, 2002.
  • 7Schiano TD. Complications of chronic liver disease. In: Friedman S, Grendell J, McQuaid K, editors. Current Di- agnosis and Treatment in Gastroenterology. 2nd ed. Lange Current Series, 2002.
  • 8Blei AT, Córdoba J. Hepatic Encephalopathy. Am J Gastro- enterol 2001; 96: 1968-1976.
  • 9Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy--def inition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-721.
  • 10Zeneroli ML, Avallone R, Corsi L, Venturini I, Baraldi C, Baraldi M. Management of hepatic encephalopathy: role of rifaximin. Chemotherapy 2005; 51 Suppl 1: 90-95.

共引文献10

同被引文献12

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部